K.B. declares no competing interests. O.E. is the Principal Investigator for research projects funded by Dexcom, Eli Lilly, Vertex and Medtronic Diabetes through his organization T1D Exchange. O.E. is also a member of the Medtronic Diabetes Health Inequity and Sanofi Advisory Board and has received speaker fees from Vertex and Medtronic Diabetes. K.H. declares no competing interests. J.J.M. declares having participation on a Data Safety Monitoring Board or Advisory Board (unpaid) - DSMB, Nigeria Sodium Study (NaSS); a trial Steering Committee, INTEnsive care bundle with blood pressure Reduction in Acute Cerebral haemorrhage Trial (INTERACT 3); an International Advisory Board, Latin American Brain Health institute (BrainLat), Universidad Adolfo Ibáñez (Chile); a Consultative Board, Programa de Gastronomía, Facultad de Estudios Interdisciplinarios, Pontificia Universidad Católica del Perú; and an Advisory Board, InterAmerican Heart Foundation (IAHF). J.J.M is an unpaid co-Chair, Independent Group of Scientists (IGS), 2023 Global Sustainable Development Report, United Nations. J.J.M. is a member of the Scientific Expert Committee, Global Data Collaborative for CV Population Health, World Health Federation, Microsoft and Novartis Foundation; a member of the Scientific and Technical Advisory Committee (STAC), Alliance for Health Policy and Systems Research, World Health Organization; a member of the WHO Technical Advisory Group on NCD-related Research and Innovation (TAG/RI), Noncommunicable Diseases Department, World Health Organization and a member of the Advisory Scientific Committee, Instituto de Investigación Nutricional (Peru). S.S. has received speaker honoraria from: AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, MSD, Novo Nordisk, SB Communications, OmniaMed, Roche, Napp, NB Medical, Amgen, Abbott and Meranini. S.S. has received advisory board honoraria from: AstraZeneca, Lilly, Boehringer Ingelheim, Janssen, MSD, Novo Nordisk, Napp, Takeda, Sanofi and Meranini. S.S. has received educational grants from: Boehringer Ingelheim, Lilly, Novo Nordisk, Takeda. S.S. has received conference registration and subsistence from: Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, Takeda. S.S. has received research grants from Sanofi.